Congenital Athymia Patient Registry
Recruiting · NCT05329935
Conditions: Complete DiGeorge Anomaly, Complete DiGeorge Syndrome, Congenital Athymia
At a glance
- Research payments reported, 2025
- $828,285
- U.S. investigators named
- 8
- Sites paid
- 8
- Planned or actual enrollment
- 75
About the trial
- Sponsor
- Sumitomo Pharma Switzerland GmbH
- Tested
- Cultured Thymus Tissue (biological)
- Dates
- Started 2022-05-25; completion 2026-04
- Results posted
- Not yet
This Congenital Athymia Patient Registry is an observational exposure-based registry study. It uses a prospective cohort design to follow patients who have been treated with RETHYMIC. Clinical studies conducted with investigational RETHYMIC showed that treatment can result in immune reconstitution and prolong life. This treatment-based registry is being conducted to learn more about the reconstitution process following treatment and the impact of treatment on longer-term survival and the occurrence of adverse events of special interest (AESI).
From ClinicalTrials.gov, last updated 2025-08-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sumitomo Pharma America, Inc. reported $828,285 in research payments for this study in 2025 (47 payments).
Products named: Rethymic
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- James Jaggers, MD Cardiothoracic Surgery · Aurora, CO
- Keith Sacco, MD Allergy & Immunology · Jacksonville, FL
- Subhadra Shashidharan, M.D Cardiothoracic Surgery · Atlanta, GA
- John W. Sleasman, MD Pediatrics · Durham, NC
- Eveline Y. Wu, MD Allergy & Immunology · Chapel Hill, NC
- Rabi Hanna, M.D Pediatric Hematology & Oncology · Cleveland, OH
- Jennifer R. Heimall, MD Pediatrics · Philadelphia, PA
- Larry Borish Allergy & Immunology · Charlottesville, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Duke University $465,235
- Phoenix Children's Hospital, AZ $217,500
- Childrens Healthcare of Atlanta Inc $42,920
- University of Virginia Medical Center, VA $37,062
- Cleveland Clinic, OH $23,626
- University of North Carolina at Chapel Hill $23,162
- Children's Hospital of Philadelphia, PA $17,280
- Children's Hospital Colorado, CO $1,500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.